Grant approvals committee

4.

Strong role for private sector in Global Fund's TB grants to India

6 Feb 2018
India has ambitious goal to end TB by 2025

Among the grants approved by the Board recently were four TB grants and one TB/HIV grant to India. In this article, we report on the comments from the Technical Review Panel (TRP) and the Grants Approvals Committee (GAC) on the funding request from which these grants emanated.

3.

The Global Fund's TRP praises India for ambitious plan to fast track the end of the HIV epidemic

6 Feb 2018
However, the TRP expressed concern about the absence of human rights- and gender-responsive programming

When it reviewed India’s HIV funding request in 2017, the Technical Review Panel (TRP) commended the Government of India for its ambitious plan to fast track the end of the HIV epidemic. At the same time, however, the TRP raised concerns about what it viewed as the request’s failure to include a focus on human rights and gender.

1.

Political instability, decreasing resources and a resurgent malaria epidemic: A challenging environment for Global Fund grants in Burundi

6 Feb 2018
Malaria incidence doubled between 2014 and 2016
1.

TRP focuses on gaps in services for key populations in its review of Ethiopia's TB/HIV funding request to the Global Fund

23 Jan 2018
Concerns raised regarding sustainability of national programs

When the Technical Review Panel (TRP) assessed Ethiopia’s TB/HIV funding request last Fall, it considered the request to be technically sound, but expressed concerns related to coverage of key populations.

5.

TRP praises Kenya's TB/HIV funding request to the Global Fund for its sensitivity to key populations and human rights

23 Jan 2018
Devolution cited as both an opportunity and a challenge
8.

Zambia’s TB/HIV funding request to the Global Fund has ambitious targets and is well aligned with national programs and strategies

9 Jan 2018
TRP’s concerns regarding interventions for key populations addressed during grant-making

The third batch of funding approvals by the Board (see GFO article) included two TB/HIV grants from Zambia. In this article, we report on the comments from the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on the funding requests from which these grants emanated.

5.

Mozambique’s TB/HIV funding request to the Global Fund builds on achievements of current grants, TRP says

9 Jan 2018
Matching funds requests sent back for iteration

Among the grants approved by the Board in the third batch of funding (see GFO article) were four TB/HIV grants to Mozambique. In this article, we report on the comments of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on the funding request from which these grants emanated.

2.

Extensions to the Global Fund’s existing HIV and TB grants to Nigeria will be funded from the 2017–2019 allocations

9 Jan 2018
GAC reports “widespread frustration” about the slow pace of impact of the TB grants

As mentioned elsewhere in this issue, the Board has approved 18-month costed extensions for two HIV and two TB grants to Nigeria.

10.

GAC and TRP comment on Global Fund grants to Burkina Faso

9 Jan 2018
Health systems activities rolled into the malaria grant

Among the grants approved by the Board in December were HIV, TB/HIV and malaria grants for Burkina Faso. This article provides a summary of the comments of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on all three grants.

1.

Ambitious national targets for getting people on treatment often not reflected in grant performance frameworks, GAC says

13 Dec 2017
The reason? “Limitations of budgets in the 2017-2019 allocations period”
GAC calls for urgent inter-agency discussions, with donor governments included

In its report to the Board on the third batch of grants it recommended for approval, the Grant Approvals Committee (GAC) said that it was very concerned that national programs have ambitious goals to continue scaling up antiretroviral therapy (ART), with the aim of achieving the 90-90-90 targets or even treating all patients diagnosed with HIV – but that these goals are not necessarily reflected in performance frameworks because of “limitation

Pages

Subscribe to Grant approvals committee